BioMarin Pharmaceutical
NASDAQ: BMRN
$86.71
-$3.51 (-3.9%)
Closing price January 18, 2022
Monday afternoon's analyst upgrades and downgrades included Activision Blizzard, BioMarin, eBay and Teladoc.
1 month ago
Thursday's top analyst upgrades and downgrades included AT&T, Alibaba, Ally Financial, BioMarin Pharmaceutical, Box, Citrix Systems, Nio, Schlumberger and TJX Companies.
3 months ago
Last Updated: 3 months ago
Thursday’s top analyst upgrades and downgrades included Baker Hughes, BioMarin Pharmaceutical, Cisco Systems, Haliburton, Macy’s, Schlumberger and Sherwin-Williams.
4 months ago
Last Updated: 4 months ago
Friday's top analyst upgrades and downgrades included ADS, BioMarin Pharmaceutical, Dick's Sporting Goods, Freeport-McMoRan, Northrop Grumman, Simon Properties and U.S. Steel.
7 months ago
Last Updated: 7 months ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
8 months ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Anthem, BioMarin, CRISPR, GE and more.
10 months ago
Last Updated: 10 months ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including BioCryst, Editas, Groupon, Sunrun, Twitter and more.
10 months ago
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...
1 year ago
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic...
1 year ago
Thursday's top analyst upgrades and downgrades included BioMarin Pharmaceuticals, Checkpoint Software Technologies, Cinemark, Fortinet, Palo Alto Networks, Regeneron Pharmaceuticals, Shake Shack,...
1 year ago
Last Updated: 1 year ago
BioMarin Pharmaceutical stock was crushed on Wednesday after an FDA response regarding its valoctocogene roxaparvovec gene therapy for severe hemophilia A.
1 year ago
Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of the year.
1 year ago
Last Updated: 1 year ago
Wednesday's top analyst upgrades and downgrades Apple, Boeing, Chevron, Chewy, Cisco Systems, Cree, eBay, Etsy, GameStop, Groupon, Micron Technology, United Airlines and Yext.
1 year ago
Last Updated: 1 year ago
These five high-conviction health care picks make sense for accounts looking to gain exposure to a sector that should continue to do well the rest of 2020 and for years to come, given the aging...
1 year ago
Last Updated: 1 year ago
With the potential for continued economic and political volatility, now is probably a good time for a little spring cleaning to portfolios. Here are six new additions to the Jefferies Franchise Picks...
1 year ago